U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185399) titled 'Systems Biological Analysis of Immune Responses to RSV Vaccine' on Sept. 15.
Brief Summary: The purpose of this study is to characterize the immune response to the FDA-approved mRNA-based RSV vaccine in adults >=60 years of age, using a systems biology approach. The study aims to generate high-resolution immunologic and systems biology data following vaccination to identify early biomarkers of response and gain mechanistic insight into host immunity.
Study Start Date: Sept. 22
Study Type: INTERVENTIONAL
Condition:
Respiratory Syncytial Virus (RSV)
Intervention:
BIOLOGICAL: Moderna RSV vaccine
Participants will receive the MR...